Tech Company M&A Transactions
Aragon Pharmaceuticals Acquisition
Aragon Pharmaceuticals was bought by Johnson & Johnson. The transaction occurred on 6/17/2013. Johnson & Johnson said the transaction price was $1 billion.
Transaction Overview
Company Name
Acquired By
Announced On
6/17/2013
Transaction Type
M&A
Amount
$1,000,000,000
M&A Terms
J&J will pay $650 million upfront and potential milestone payments of up to $350 million.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12780 El Camino Real 301
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Email Address
Overview
Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Paul Cleveland
Chief Medical Officer
Isan Chen
President
Richard Heyman
VP - Bus. Development
Angie You
Browse more venture capital transactions:
Prev: 6/17/2013: Minimally Invasive Devices venture capital transaction
Next: 6/17/2013: Silvergate Pharmaceuticals venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs